Table 5 Multivariate analysis in the validation cohort excluding high EVI1 cases
From: A standardized microarray assay for the independent gene expression markers in AML: EVI1 and BAALC
Variable | p-value | HR | 95% CI |
|---|---|---|---|
BAALC-low | 0.035 | 1.56 | 1.03–2.54 |
CEBPA-dm | 0.047 | 0.35 | 0.12–0.98 |
NPM1-ABD | 0.36 | 0.82 | 0.53–1.26 |
FLT3-ITD | 0.038 | 1.56 | 1.02–2.39 |
age in years | 0.012 | 1.02 | 1.00–1.04 |
gender | 0.74 | 1.07 | 0.72–1.58 |
White blood Cell Count at diagnosis [×10^9/l] | 0.14 | 1.00 | 1.00–1.00 |
Percentage of blast cells in bone marrow | 0.2 | 0.99 | 0.99–1.00 |
Platelets at diagnosis [×10^9/l] | 0.28 | 1.00 | 1.00–1.00 |